Far Peak Acquisition, the second blank check company formed by former NYSE President Tom Farley to acquire a fintech, filed on Monday with the SEC to raise up to $550 million in an initial public offering.
The New York, NY-based company plans to raise $550 million by offering 55
Highland Transcend Partners I, a blank check company formed by Highland Capital Partners targeting disruptive commerce, digital media, and enterprise software, filed on Monday with the SEC to raise up to $250 million in an initial public offering.
The Cambridge, MA-based company
Airbnb, which provides a platform for booking short-term stays from a global network of locals, filed on Monday with the SEC to raise up to $1.0 billion in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $3.0 billion.
Ai
10X Capital Venture Acquisition, a blank check company formed by 10X Capital targeting a tech-enabled business, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also removed Cantor Fitzgerald as an underwriter and added Wells Fargo
Lixte Biotechnology Holdings, a Phase 2 biotech using biomarker technology to develop protein inhibitors for cancer, lowered the proposed deal size for its upcoming Nasdaq IPO on Monday. In its latest filing, the company also changes the security type offered to units from common
L&F Acquisition, a second blank check company formed by Victory Park Capital targeting governance, risk, compliance and legal tech, lowered the proposed deal size for its upcoming IPO on Monday.
The Chicago, IL-based company now plans to raise $150 million by offering 15 mil
Aequi Acquisition, a blank check company targeting data-centric, growth-oriented companies with established business models, lowered the proposed deal size for its upcoming IPO on Monday.
The Greenwich, CT-based company now plans to raise $200 million by offering 20 million unit
Olema Pharmaceuticals, a clinical-stage biotech developing therapies for women's cancers, announced terms for its IPO on Monday.
The San Francisco, CA-based company plans to raise $170 million by offering 10 million shares at a price range of $16 to $18. At the midpoint of the p
Updated Monday, 11/16.
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.6 billion in the week ahead.
Biotech research product provider Maravai LifeSciences (MRVI) plans to raise $1.3 billion at a $6.6 billi
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead.
Biotech research product provider Maravai LifeSciences (MRVI) plans to raise $1.3 billion at a $6.6 billion market cap. Maravai pro
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.4 billion in the week ahead.
Biotech research product provider Maravai LifeSciences (MRVI) plans to raise $1.3 billion at a $6.6 billion market cap. Maravai p
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.4 billion in the week ahead.
Biotech research product provider Maravai LifeSciences (MRVI) plans to raise $1.3 billion at a $6.6 billion market cap. Maravai p
Eight SPACs went public this past week but no IPOs, as all three scheduled deals postponed or withdrew. New filing activity picked up, led by long-awaited delivery service unicorn DoorDash (DASH), and several launches indicate increased activity in the coming weeks.
Three biotec
Eight SPACs went public this past week but no IPOs, as all three scheduled deals postponed or withdrew. New filing activity picked up, led by long-awaited delivery service unicorn DoorDash (DASH), and several launches indicate increased activity in the coming weeks.
Three biotec
Kinnate Biopharma, an oncology biotech developing small molecule kinase inhibitors, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Kinnate is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-tr
BioAtla, a Phase 2 biotech developing antibody therapies for solid tumor cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The company is developing a novel class of specific and selective antibody-based therapeutics. Its conditiona
C3.ai, which provides SaaS applications for the deployment of enterprise AI applications, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The company provides SaaS applications that enable the rapid deployment of enterprise-scale AI applic
C3.ai, which provides SaaS applications for the deployment of enterprise AI applications, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
The company provides SaaS applications that enable the rapid deployment of enterprise-scale AI applic
PubMatic, which provides a cloud infrastructure platform that enables advertising transactions, filed on Friday with the SEC to raise up to $75 million in an initial public offering.
The company provides a specialized cloud infrastructure platform that enables real-time programm
17 Education & Technology Group, which provides K-12 education services in China, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
17 Education & Technology's smart in-school classroom solution delivers data-driven teaching, learnin
Renaissance Capital
Checked
4 minutes 16 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs